The investment will support ABAlife’s next phase of growth, including developing clinical intelligence solutions, accelerating industrialization and underpinning its international expansion across Africa and other emerging markets.

This transaction is a strong signal of investor appetite for African-built HealthTech, and of Morocco’s growing role as a hub for innovation that can be deployed across the continent.

Proud to have supported on this significant mandate. Partner Safia Fassi Fihri led the transaction, assisted by senior associates Sarah Rachedi and Ghita Berrada.